Dendreon
Highly Engaged Employees
Highly Engaged EmployeesChemicals & Related Products · California, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
1700 Saturn Way, Seal Beach, California,...Phone Number
(877) 256-4545Website
www.dendreon.comRevenue
$255.7 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
5
1
1
1
1
About Dendreon
Founded in 1992 and headquartered in Seal Beach, California, Dendreon is a biotechnology company that specializes in the development and manufacturing of immune-therapeutics for the treatments of cancers.Explore more
Dendreon Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Dendreon your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Dendreon launches new products
Earning: See what the market has to say on Dendreon recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Dendreon
Check if Dendreon has recently received funding, and reach out quickly before it becomes old news!
Dendreon, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Dendreon had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check out if Dendreon is spiking on competitors!
Funding: Get notified immidiatlly once Dendreon has new funding data
Recommended Actions
Find VP level buyers at Dendreon
Find 3 more new buyers
Compare Similar Companies to Dendreon
Compare insights from companies similar to Dendreon, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$675.1M
1K - 5K
Private
$225M
2009
KD
Kristen DravesDirector, Head of Business Strategy and Operations. Chief of Staff
Company Profile Activity
Activity Insights
Dendreon is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Dendreon is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Dendreon.
Dendreon financials insights
Gather financial insights about Dendreon, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2000
Stock Offering
$45M
2020
Debt
$5M
Dendreon Tech Stack
A closer look at the technologies used by Dendreon
Most Recent Scoops
Hiring Plans
Dendreon has more open roles in Operations than it has had at any time in the past 12 months. Areas of expertise include: Technology Transfer, Operational Excellence, Customer Experience Improvement, Calibration, Supply Management, Operationalization, and Strategic Prioritization.
Hiring Plans
Hiring Plans
Dendreon has more open roles in Sales than it has had at any time in the past 6 months. Areas of expertise include: Managing Large Accounts, and Account Management.
Hiring Plans
Event
Product Marketing, Events, Training, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Technology
Event
Product Marketing, Events, Software, Field /Outside Sales, Field Marketing, Healthcare Operations, Healthcare Technology
Event
Events
Dendreon News & Media
Dendreon Pharmaceuticals and Shoreline Biosciences Announce CMC and Manufacturing Alliance to Advance the Future of iPSC Cellular Therapy
SEAL BEACH, Calif. & SAN DIEGO--(BUSINESS WIRE)--Dendreon Pharmaceuticals, a commercial-stage biopharmaceutical company and pioneer in the development of cellular immunotherapy, and Shoreline Biosciences, a biotechnology company developing allogeneic off-the-shelf, standardized, and targeted natural killer (NK) and macrophage cellular immunotherapies derived from induced pluripotent stem cells (iPSC) for cancer, today announced an alliance to advance the future of iPSC-derived cellular therapieDendreon Pharmaceuticals Appoints Sherry Saurini as Vice President of Quality
SEAL BEACH, Calif.--(BUSINESS WIRE)--Dendreon Pharmaceuticals, a commercial-stage biopharmaceutical company and pioneer in the development of cellular immunotherapy, is pleased to announce the appointment of Sherry Saurini as Vice President of Quality, effective August 23, 2021. Saurini will focus on leading and managing the strategic and operational performance of the quality organization to support Dendreon’s product portfolio and contract manufacturing services division partner programs. "AfDendreon Pharmaceuticals Invests in Contract Manufacturing and Patient Services for Cell Therapy Partners
SEAL BEACH, Calif.--(BUSINESS WIRE)--Dendreon Pharmaceuticals, a commercial-stage biopharmaceutical company and pioneer in the development of cellular immunotherapy, has established and invested in its new contract manufacturing and services division to bring late-stage clinical assets through to commercialization. Leveraging its extensive manufacturing, process development and logistics expertise, Dendreon now offers end-to-end manufacturing of complex cell therapies and patient logistics for
Read more news
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Dendreon
Sign Up For FreeTo access detailed company insights
Founded in 1992 and headquartered in Seal Beach, California, Dendreon is a biotechnology company that specializes in the development and manufacturing of immune-therapeutics for the treatments of cancers.... Read More
